Publications by authors named "Peng Guangbin"

Claim this Profile
R
Regulation of mild moxibustion on non-neuronal cholinergic system in ulcerative colitis rats.
Peng Guangbin, L I Han, Zhu Lu, Q I Qin, Zheng Shiyu

J Tradit Chin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moxibustion alleviates intestinal inflammation in ulcerative colitis rats by modulating long non-coding RNA LOC108352929 and inhibiting Phf11 expression.
Guona Li, Chen Zhao, Jing Xu, Yan Huang, Yu Qiao, Guangbin Peng

Heliyon· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial.
David S Hong, Michael Postow, Bartosz Chmielowski, Ryan Sullivan, Amita Patnaik, Guangbin Peng

Clin Cancer Res· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acupuncture for Fibromyalgia: A Review Based on Multidimensional Evidence.
Dong Han, Yuan Lu, Rong Huang, Zihui Yang, Guangbin Peng

Am J Chin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deconstructing tolerance with clobazam: Post hoc analyses from an open-label extension study.
Barry E Gidal, Robert T Wechsler, Raman Sankar, Georgia D Montouris, H Steve White, Guangbin Peng

Neurology· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clobazam-treated patients with Lennox-Gastaut syndrome experienced fewer seizure-related injuries than placebo patients during trial OV-1012.
Jouko Isojarvi, Deborah Lee, Guangbin Peng, Michael R Sperling

Epilepsia· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: Pooled tolerability results from two open-label trials.
Deborah Lee, Uwa Kalu, Jonathan J Halford, Victor Biton, James Cloyd, Guangbin Peng

Epilepsia· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploratory subgroup analysis of race and gender in squamous cancer of the head and neck: inferior outcomes for African American males in the LORHAN database.
D Neil Hayes, Guangbin Peng, Eduardo Pennella, Anwar Hossain, Gebra Cuyun Carter

Oral Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancer.
Hak Choy, Lee S Schwartzberg, Shaker R Dakhil, Edward B Garon, David E Gerber, Guangbin Peng

J Thorac Oncol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer.
Myung-Ju Ahn, James Chih-Hsin Yang, Jun Liang, Jin-Hyoung Kang, Qingyu Xiu, Guangbin Peng

Lung Cancer· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): a combined analysis of three phase 3 trials.
Joseph Treat, Giorgio V Scagliotti, Guangbin Peng, Matthew J Monberg, Coleman K Obasaju

Lung Cancer· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.
Waldo Ortuzar, Nasser Hanna, Eduardo Pennella, Guangbin Peng, Corey Langer

Clin Lung Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, phase II trial of pemetrexed and carboplatin with or without enzastaurin versus docetaxel and carboplatin as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer.
Mark A Socinski, Robert N Raju, Thomas Stinchcombe, Darren M Kocs, Linda S Couch, Guangbin Peng

J Thorac Oncol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology.
Ralph G Zinner, Scott B Saxman, Guangbin Peng, Matthew J Monberg, Waldo I Ortuzar

Clin Lung Cancer· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in stress urinary incontinence episodes: what is clinically important for women?
Ilker Yalcin, Guangbin Peng, Lars Viktrup, Richard C Bump

Neurourol Urodyn· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials.
Ralph G Zinner, Silvia Novello, Guangbin Peng, Roy Herbst, Coleman Obasaju

Clin Lung Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer.
Craig Reynolds, Coleman Obasaju, Michael J Schell, Xueli Li, Zhong Zheng, Guangbin Peng

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer.
M Patricia Rivera, Frank C Detterbeck, Mark A Socinski, Dominic T Moore, Martin J Edelman, Guangbin Peng

Chest· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS).
Richard J Gralla, Martin J Edelman, Frank C Detterbeck, Thierry M Jahan, David M Loesch, Guangbin Peng

Support Care Cancer· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
George R Simon, Claire F Verschraegen, Pasi A Jänne, Corey J Langer, Afshin Dowlati, Guangbin Peng

J Clin Oncol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis